findmyKOL
Clinical trialNCT03219268CompletedPhase 1Interventional

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

SponsorMacroGenicsEnrollment277Advanced Solid TumorsCervical CancerCholangiocarcinomaHER2-positive Advanced Solid TumorsHematologic NeoplasmsNon Small Cell Lung Cancer+4 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • St Vincent'S Hospital Sydney

    Darlinghurst, New South Wales, Australia

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia

  • Southern Medical Day Care Centre

    Wollongong, New South Wales, Australia

  • Austin Health Melbourne

    Heidelberg, Victoria, Australia

Bulgaria
  • "complex Oncology Center - Burgas" Eood

    Burgas, Bulgaria

  • "acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda" Ead, Sofia

    Sofia, Bulgaria

  • Multiprofile Hospital for Active Treatment "serdika" Eood, Sofia

    Sofia, Bulgaria

Hong Kong
  • Prince of Wales Hospital

    Shatin, Hong Kong

Poland
  • Pratia Mcm Kraków

    Krakow, Lesser Poland Voivodeship, Poland

  • Biovirtus Research Site Sp. Z O.O. / Biovirtus Centrum Medyczne

    Józefów, Masovian Voivodeship, Poland

  • Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy

    Warsaw, Masovian Voivodeship, Poland

  • Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy

    Warsaw, Masovian Voivodeship, Poland

  • Med-Polonia Sp. Z O.O.

    Poznan, Poland

Spain
  • Vall D'Hebron Institute of Oncology

    Barcelona, Spain

  • Hospital Ruber Internacional

    Madrid, Spain

  • Start Madrid-Ciocc, Hospital Hm Sanchinarro

    Madrid, Spain

Thailand
  • King Chulalongkorn Memorial Hospital

    Bangkok, Thailand

  • Maharaj Nakorn Chiang Mai Hospital

    Chiang Mai, Thailand

  • Songklanagarind Hospital

    Songkhla, Thailand

Ukraine
  • Communal Nonprofit Enterprise "cherkassy Regional Oncology Dispensary" of Cherkassy Regional Council

    Cherkassy, Cherkasy Oblast, Ukraine

  • Communal Nonprofit Enterprise Podillia Regional Center of Oncology of Vinnytsia Regional Council

    Vinnytsia, Vinnytsa Region, Ukraine

  • Communal Non-Profit Enterprise "city Clinical Hospital #4" of Dnipro City Council

    Dnipro, Ukraine

  • Communal Nonprofit Enterprise "prykarpatsky Clinical Oncological Centre of Ivano-Frankivska Regional Council"

    Ivano-Frankivsk, Ukraine

  • Municipal Non-Profit Enterprise of Sumy Regional Council "sumy Regional Clinical Oncology Dispensary"

    Sumy, Ukraine

  • Communal Nonprofit Enterprise "central City Clinical Hospital of Uzhhorod City Council", City Oncology Center, State Higher Educational Institution <<uzhhorod National University>>

    Uzhhorod, Ukraine

United States
  • Banner Md Anderson Cancer Center

    Gilbert, Arizona, United States

  • Ucla Hematology & Oncology Clinic

    Los Angeles, California, United States

  • Usc/norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, United States

  • Florida Cancer Specialists & Research Institute

    Sarasota, Florida, United States

  • University of Chicago Medicine

    Chicago, Illinois, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, United States

  • Massachusetts General Hospital and Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • Stephenson Cancer Center, the University of Oklahoma

    Oklahoma City, Oklahoma, United States

  • University of Pennsylvania, Abramson Cancer Center

    Philadelphia, Pennsylvania, United States

  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

  • Sarah Cannon Research Institute

    Nashville, Tennessee, United States

  • the University of Texas M.D. Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Aug 2017
Primary completion
8 Feb 2023
Completion
8 Feb 2023
Last update posted
21 Dec 2023
Registered enrollment
277
Registry id
NCT03219268

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.